NMS·Healthcare·$1.3B·#175 / 520 in Healthcare
KMTS Kestra Medical Technologies, Lt
55SPECULATIVE
CATEGORY BREAKDOWN
GROWTH84
QUALITY43
STABILITY63
VALUATION31
GOVERNANCE38
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
+59.0%
84
> 50% strong
Gross Margin
Revenue retained after direct costs
51.4%
72
> 50% strong
Cash Runway
Months of cash at current burn rate
15 months
51
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
18.0%
86
< 25% strong
Price / Sales
Market cap relative to trailing revenue
14.1x
31
< 3x strong
Rule of 40
Growth rate plus operating margin
-83
0
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
5.7%
43
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
+14.1%
28
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE KMTS WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when KMTS's score changes by 5+ points.
DATA INFO
Last updated: Aug 1, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.